Efficacy of Postoperative Transarterial Chemoembolization and Portal Vein Chemotherapy for Patients with Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis—a Randomized Study
✍ Scribed by Q. Li; J. Wang; Y. Sun; Y.L. Cui; J.T. Juzi; H.X. Li; B.Y. Qian; X.S. Hao
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 122 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## METHODS. Nine patients with HCC were treated by arterial infusion of a chemotherapeutic agent via a subcutaneously implanted injection port. One course consisted 1 Second Department of Medicine, Kurume Uniof the daily administration of cisplatin (10 mg for 1 hour on Days 1-5) and the versity Sc
## Background: The prognosis of patients with hepatocellular carcinoma (hcc) with portal vein tumor thrombosis (pvtt) is extremely poor. the aim of this study was to elucidate the efficacy of hepatic arterial infusion chemotherapy (haic) for patients with advanced hccs. ## Methods: Forty-eight hc
## Background: Transcatheter arterial chemoembolization (tace) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (hcc) and main portal vein (mpv) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after tace. the current co